Allose
|
Basic information |
| Metabolite name | Allose |
 | HMDB0001151 |
 |
C01487 |
 |
12285879 |
| Synonyms | D-Allose |
| No. of studies | 7 |
|
Basic information |
| Metabolite name | Allose |
| HMDB0001151 |
|
C01487 |
|
12285879 |
| Synonyms | D-Allose |
| No. of studies | 7 |
|
Relationship between Allose and depression (count: 7) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M1047 | Type2 | CSDS + 3,4-methylenedioxymethamphetamine group vs. CSDS group | Plasma | C57BL/6 mouse | Up |
| Study M464 | Type1 | drug-naive MDD group vs. control group | Plasma | Human | Up |
| Study M464 | Type1 | drug-treatment MDD group vs. control group | Plasma | Human | Up |
| Study M487 | Type1 | CUMS group vs. control group | Plasma | Sprague-Dawley rat | Up |
| Study M547 | Type1 | CUMS group vs. control group | Faece | Sprague-Dawley rat | Down |
| Study M547 | Type1 | CUMS group vs. control group | Plasma | Sprague-Dawley rat | Up |
| Study M555 | Type1 | FMT group vs. control group | Liver | Sprague-Dawley rat | Up |
| Study M971 | Type1 | CUMS group vs. control group | Serum | Sprague-Dawley rat | Down |
| Study M981 | Type1 | Abeta oligomer group vs. control group | Serum | ICR mouse | Up |
| Study M981 | Type2 | Abeta oligomer + involuntary and voluntary running group vs. Abeta oligomer group | Serum | ICR mouse | Down |